GlassScriptPhysician profile
Thomas G Heffron
NPI 1063522423
$18,161.33
in general payments reported to CMS, 2019-2025
22 companies · $2,767 in 2025
The $2,767 reported for 2025 was more than what 78% of Transplant Surgery providers received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,270 · 2020: $1,178 · 2021: $3,742 · 2022: $988 · 2023: $836 · 2024: $2,381 · 2025: $2,767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,634 · Travel and Lodging: $2,341 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,633.67 |
| Travel and Lodging | $2,341.28 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,597.42 | 2019-2024 | |
| Histosonics, INC. | $1,467.25 | 2024-2025 | |
| Davol INC. | $1,404.02 | 2019-2025 | Phasix Mesh, Arista Ah Flexitip |
| Tela Bio, INC. | $1,060.33 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $908.68 | 2021-2025 | Signia, Osteocool Rf Ablation System, Emprint |
| Boston Scientific Corporation | $786.01 | 2022-2025 | Therasphere Administration Set, Therasphere Y90 Glass Microspheres 10 Gbq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $160.77 | 2022-2025 | Xifaxan |
| Mallinckrodt Hospital Products INC. | $133.61 | 2024 | Terlivaz |
| Intercept Pharmaceuticals, INC. | $113.40 | 2024 | |
| Echosens North America, INC. | $105.21 | 2022 | |
| Avanos Medical | $83.80 | 2022 | |
| Ethicon US, LLC | $76.44 | 2022-2023 | Echelon; Endopath |
| Gilead Sciences, INC. | $52.57 | 2021-2023 | Epclusa |
| Heartflow, INC. | $45.30 | 2022 | |
| Dilon Technologies, INC. | $32.82 | 2024 | Hemoblast Bellows |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $31.39 | 2025 | Fibryga |
| Ipsen Biopharmaceuticals, INC | $22.70 | 2025 | Iqirvo |
| Conmed Corporation | $20.81 | 2023 | Visiclear, Abc Handpieces |
| Haemonetics Corporation | $20.29 | 2023 | Teg5000 Hemostasis Analyzer |
| Potrero Medical, INC. | $16.34 | 2021 | |
| Eisai INC. | $12.28 | 2021 | |
| Aroa Biosurgery Incorporated | $9.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Heffron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.